XML 51 R20.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of loss (income) before income taxes

 

   
Year ended December 31
 
   
2022
   
2021
 
Entera Bio Ltd.
   
12,997
     
12,362
 
Entera Bio Inc.
   
(65
)
   
(116
)
Total loss before taxes
   
12,934
     
12,246
 
 
Schedule of tax expenses
   
Year ended December 31
 
 
 
2022
   
2021
 
Current:
           
Subsidiary:
   
(37
)    
158
 
Total current income tax
   
(37
)    
158
 
Deferred income taxes
    174       (217 )
Total deferred income taxes
   
174
 
    (217 )
Total income tax expense (benefit) 
   
137
 
   
(59
)

 

Schedule of deferred income taxes
   
December 31,
 
   
2022
    2021  
Deferred tax assets:
           
Net operating loss carry forward
   
15,428
     
12,895
 
Research and development
   
1,225
     
1,319
 
Share-based compensation
   
877
     
876
 
Other
   
158
     
152
 
Net deferred tax assets before valuation allowance
   
17,688
     
15,242
 
Valuation allowance
   
(17,645
)
   
(15,025
)
Net deferred tax assets
   
43
     
217
 
 
Schedule of rollforward of valuation allowance
Balance at January 1, 2021
 

12,420

 

Additions

 

2,605

 

Balance at January 1, 2022

 

15,025

 

Additions

 

2,620

 

Balance at December 31, 2022

 

17,645